Buflomedil structure
|
Common Name | Buflomedil | ||
---|---|---|---|---|
CAS Number | 55837-25-7 | Molecular Weight | 307.385 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 454.5±45.0 °C at 760 mmHg | |
Molecular Formula | C17H25NO4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 228.7±28.7 °C |
Use of BuflomedilBuflomedil is an orally active vasoactive agent. Buflomedil is an α1-, α2-adrenolytic compound. Buflomedil can be used for research of cardiovascular disease, such as peripheral vascular disease[1][2]. |
Name | Buflomedil |
---|---|
Synonym | More Synonyms |
Description | Buflomedil is an orally active vasoactive agent. Buflomedil is an α1-, α2-adrenolytic compound. Buflomedil can be used for research of cardiovascular disease, such as peripheral vascular disease[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 454.5±45.0 °C at 760 mmHg |
Molecular Formula | C17H25NO4 |
Molecular Weight | 307.385 |
Flash Point | 228.7±28.7 °C |
Exact Mass | 307.178345 |
PSA | 48.00000 |
LogP | 2.46 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.520 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
HS Code | 29339990 |
---|
4-(1-Pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone |
1-Butanone, 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)- |
Buflomedil |
BufluomedilHcl |
EINECS 259-851-3 |
AURORA KA-850 |
4-pyrrolidin-1-yl-1-(2,4,6-trimethoxyphenyl)butan-1-one |
4-pyrrolidin-1-yl-1-[2,4,6-tris(methyloxy)phenyl]butan-1-one |
4-(Pyrrolidin-1-yl)-1-(2,4,6-trimethoxyphenyl)butan-1-one |
MFCD00242740 |
4-(Pyrrolidin-1-yl)-1-(2,4,6-trimethoxyphenyl)butan-1-on |
(2,4,6-Trimethoxyphenyl) (3-Pyrrolidinopropyl) Ketone |